IRWD
NASDAQ · Biotechnology
Ironwood Pharmaceuticals Inc
$4.03
+0.26 (+6.90%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,182.9% upside
Low Target
$40.79
Average Target
$51.70
High Target
$62.56
Current Price
$4.03
Current
$4.03
$4.03
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Scenario Analysis
Bear Case
$40.79
912.2%
Low target
Base Case
$51.70
+1,182.9%
Avg target
Bull Case
$62.56
+1,452.4%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$5.78
-30.3% from high
52-Week Low
$1.76
+129.0% from low
Target vs 52W High
$51.70
+794.5% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $0.33
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |